Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-170.82%
-248.35%
168.53%
68.7%
44.89%
32.7%
ROA
-151.53%
-196.38%
-
-
-
-
Gross Margin
100%
100%
100%
100%
100%
100%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Total Assets
SEK 16,217.66K
SEK 305.58K
SEK 318.57K
SEK 364.49K
SEK 412.53K
SEK 439.91K
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Pila Pharma AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 17,002.47K
-SEK 16,224.52K
-SEK 16,914.06K
-SEK 19,352.02K
-SEK 21,902.47K
-SEK 23,356.55K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 94,105.17K
SEK 89,799.36K
SEK 93,615.83K
SEK 107,109.46K
SEK 121,225.67K
SEK 129,273.72K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 2.06
SEK 1.97
SEK 2.05
SEK 2.34
SEK 2.65
SEK 2.83
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Pila Pharma AB (publ) (PILA.ST) Financial Forecast | Equlion
